Protagenic (PTIX) - Company Cash Volume

Official company branding of Protagenic Therapeutics Inc. (PTIX)

Protagenic Therapeutics focuses on the ethical development of peptides for depression and biosafety. The cash liquidity history on the GURU.Markets chart demonstrates fund dynamics, where 0.00 determines the current status of the parameter. The success of Protagenic Therapeutics (PTIX) is based on regulatory approvals and venture financing. The company's development relies on clinical progress in the therapy of neuroendocrine disorders, remaining independent of macroeconomic cycles.

PTIX - protagenic.com Company Cash Reserve over the range 07/04/2022 - 01/10/2026

Analytical breakdowns for Protagenic Therapeutics

Fundamental company valuation:Protagenic Therapeutics, Inc.
Brand item of Protagenic Therapeutics

This indicator reflects the actual volume of liquid assets in the issuer's accounts, excluding accounting adjustments. By analyzing the cash reserve metric, an investor assesses the real ability of Protagenic Therapeutics (PTIX) to withstand sudden financial shocks. Daily price action eliminates speculative uncertainty, demonstrating the net balance of the money supply. For Protagenic Therapeutics (PTIX), such transparency is critical when funding the development of peptide drugs via the TCAP platform. Sufficient capital guarantees technological leadership in the fight against depression.

Competitors of Protagenic Therapeutics (PTIX)

Company Cash Volume BIIB|Company Cash Funds NBIX (Neurocrine Biosciences)|Company Cash Funds Regencell Bioscience Ltd RGC|AXSM (Axsome Therapeutics, Inc.) - Company Total Cash Volume|ACADIA Corp - Company Cash Volume|Company Cash Reserve Xenon Pharmaceuticals|VKTX (Viking Therapeutics Corp) - Company Cash on Hand|Supernus Pharmaceuticals (SUPN) - Company Cash Volume|CPRX (Catalyst Pharma) - Company Cash Volume|DNLI (Denali Therapeutics Inc.) - Company Total Cash Amount|Company Cash Volume HRMY|Biohaven Corp - Company Cash and Cash Equivalents|Company Cash Volume AMLX (amylyx.com)|Company Liquid Assets Trevi Therapeutics, Inc. (TRVI)|Praxis Corp - Company Cash Volume|Company Cash Reserve Anavex|CBLL (CeriBell Inc) - Company Cash on Hand|Company Cash and Cash Equivalents PRTA|Company Cash Funds Alector Inc.|Company Cash Reserve Annexon, Inc. ANNX|Company Cash Funds Omeros Corp (OMER)|NGNE (Neurogene Inc) - Company Cash Balance|Company Cash Funds AC Immune Inc ACIU|Company Cash Position Voyager Corp|Neumora Corp - Company Cash Volume|scilexholding.com (SCLX) - Company Cash on Hand|Tevogen Bio Holdings, Inc. (TVGN) - Company Cash Funds|Alpha Cognition Corp (ACOG) - Company Cash Volume|Company Cash on Hand CGTX|Company Cash and Cash Equivalents IKT (Inhibikase)|Company Cash Volume SAVA|Assertio - Company Cash and Cash Equivalents|Company Cash Volume COYA (Coya Therapeutics)|Company Cash Volume Vistagen Therapeutics VTGN|OVID: Company Cash on Hand|ABOS - Company Cash Volume|CRVO: Company Cash Volume|Company Cash Reserve Alterity Therapeutics Ltd. (ATHE)|Company Cash Funds Clene Inc.|pepgen.com (PEPG) - Company Liquid Assets|Company Cash on Hand JUNS (jupiterneurosciences.com)|Company Cash Funds RLMD (Relmada Corp)|Annovis Bio, Inc. - Company Cash on Hand|Company Cash Position Grace Therapeutics, Inc.|Firefly Neuroscience, Inc - Company Cash Volume|KLTO - Company Cash Volume|NRSN (NeuroSense Therapeutics Ltd.) - Company Cash on Hand|RVPH - Company Liquid Assets|Company Cash Funds MetaVia|Company Cash and Cash Equivalents NRXS (neuraxis.com)|Company Cash Funds Helius Medical Technologies (HSDT)|PASG (Passage Bio) - Company Cash Balance|Company Cash Volume NEUP (Neuphoria Therapeutics)|Company Cash Balance NERV|ATHA - Company Cash Funds|Company Total Cash Volume ADXN|ALZN (Alzamend Neuro) - Company Cash on Hand|Company Cash and Cash Equivalents CYCN|KTTA (pasitheaclinics.com) - Company Cash Volume|CRGT (cortigent.com) - Company Total Cash Amount|Company Cash Volume ATXI|Company Cash Funds BCLI (Brainstorm Cell)|Company Cash Volume CARA (Cara Therapeutics Inc)|Company Cash Balance CHRO|Eliem Therapeutics Inc. - Company Cash Volume|ITCI - Company Cash Volume|Longboard Pharma (LBPH) - Company Cash Funds|Company Cash on Hand Marinus Pharmaceuticals|Company Cash Funds NKGen|Company Cash Volume NeuroBo Pharmaceuticals, Inc.|Company Cash Volume SAGE|Synaptogenix, Inc - Company Cash and Cash Equivalents|Company Cash Funds Trevena TRVN|Company Cash Position Vigil Neuroscience|Anew Medical Inc. - Company Cash Volume|Company Liquid Assets Cerevel Therapeutics, Inc. CERE